Edition:
United States

Rockwell Medical Inc (RMTI.OQ)

RMTI.OQ on NASDAQ Stock Exchange Global Market

5.70USD
12:32pm EST
Change (% chg)

$-0.01 (-0.18%)
Prev Close
$5.71
Open
$5.66
Day's High
$5.71
Day's Low
$5.61
Volume
4,960
Avg. Vol
67,573
52-wk High
$8.97
52-wk Low
$4.86

Latest Key Developments (Source: Significant Developments)

Rockwell Medical Signs License Agreement With Quimica Europea To Commercialize Triferic In Peru
Tuesday, 12 Dec 2017 08:30am EST 

Dec 12 (Reuters) - Rockwell Medical Inc ::ROCKWELL MEDICAL SIGNS EXCLUSIVE LICENSE AGREEMENT WITH QUIMICA EUROPEA TO COMMERCIALIZE TRIFERIC IN PERU.ROCKWELL MEDICAL - SIGNED LICENSE & MANUFACTURING SUPPLY DEAL WITH QUIMICA EUROPEA FOR RIGHTS TO COMMERCIALIZE TRIFERIC FOR ESRD PATIENTS IN PERU.ROCKWELL MEDICAL INC- QUIMICA EUROPEA WILL BECOME EXCLUSIVE DISTRIBUTOR FOR TRIFERIC IN PERU FOR AN INITIAL COMMERCIAL TERM OF FIVE YEARS.ROCKWELL MEDICAL INC - ROCKWELL RETAINS MANUFACTURING RESPONSIBILITY OF ALL PRODUCTS.ROCKWELL MEDICAL- QUIMICA TO ASSUME ALL REGULATORY RESPONSIBILITIES,RELATED EXPENSES IN OBTAINING GOVERNMENT COMMERCIAL MARKETING APPROVAL FOR TRIFERIC.  Full Article

Richmond Brothers Says On Nov 22, Entered Into Settlement And Standstill Agreement With Rockwell Medical
Monday, 27 Nov 2017 05:36pm EST 

Nov 27 (Reuters) - Rockwell Medical Inc ::RICHMOND BROTHERS INC​ SAYS ON NOVEMBER 22, ENTERED INTO SETTLEMENT AND STANDSTILL AGREEMENT WITH ROCKWELL MEDICAL INC - SEC FILING.RICHMOND BROTHERS-PURSUANT TO SETTLEMENT,STANDSTILL AGREEMENT, ROCKWELL MEDICAL AGREED TO APPOINT, ONE ADDITIONAL MEMBER TO BOARD NO LATER THAN FEB 15, 2018.RICHMOND BROTHERS - STANDSTILL PERIOD SHALL TERMINATE ON FEB 15, 2018 IN EVENT THAT ADDITIONAL DIRECTOR NOT APPOINTED TO BOARD PRIOR TO FEB 15, 2018.RICHMOND BROTHERS - DURING STANDSTILL PERIOD, RICHMOND PARTIES AGREED NOT TO ACQUIRE OVER MORE THAN 12% OF ROCKWELL MEDICAL'S OUTSTANDING SHARES.  Full Article

Rockwell Medical posts Q3 loss of $0.10 per share
Wednesday, 8 Nov 2017 04:01pm EST 

Nov 8 (Reuters) - Rockwell Medical Inc :Rockwell medical reports third quarter results.Q3 loss per share $0.10.Q3 sales rose 14.1 percent to $14.6 million.  Full Article

ROCKWELL MEDICAL SAYS FDA REQUESTS EXTRA TIME TO REVIEW CALCITRIOL SUBMISSION
Wednesday, 25 Oct 2017 08:30am EDT 

Oct 25 (Reuters) - Rockwell Medical Inc ::ROCKWELL UPDATE ON CALCITRIOL POST-APPROVAL MANUFACTURING SUBMISSION TO FDA.ROCKWELL MEDICAL INC - ‍FDA HAS REQUESTED EXTRA TIME TO REVIEW ITS POST-APPROVAL DRUG MANUFACTURING SUBMISSION THAT WAS FILED WITH FDA SEPTEMBER 28.‍FDA WAS REQUIRED TO PROVIDE ROCKWELL WITH A DETERMINATION ON ITS SEPTEMBER 28(TH) SUBMISSION WITHIN 30 DAYS​.ROCKWELL MEDICAL INC - ‍ROCKWELL INTENDS TO SELL CALCITRIOL COMMERCIALLY ONCE FDA APPROVES ITS POST-APPROVAL DRUG MANUFACTURING SUBMISSION​.‍COMPANY EXPECTS TO HAVE AN ANSWER FROM FDA IN APPROXIMATELY FOUR MONTHS​.  Full Article

Rockwell files Calcitriol post-approval manufacturing submission with FDA
Thursday, 28 Sep 2017 08:30am EDT 

Sept 28 (Reuters) - Rockwell Medical Inc : :Rockwell files Calcitriol post-approval manufacturing submission with FDA.Rockwell Medical-co expects Calcitriol to be commercially available in U.S. about 30 days after CMC submission, provided FDA has no further requests.  Full Article

Rockwell Medical updates progress on calcitriol commercial launch
Wednesday, 13 Sep 2017 08:30am EDT 

Sept 13 (Reuters) - Rockwell Medical Inc ::Rockwell Medical updates progress on calcitriol commercial launch.Rockwell Medical Inc - ‍plans to submit CMC post-approval drug manufacturing supplement to FDA at end of September 2017​.Rockwell Medical- anticipates calcitriol to be commercially available in U.S. about 30 days after CMC submission, provided FDA has no further requests​.  Full Article

Richmond Brothers issues public letter to incumbent directors of Rockwell Medical
Tuesday, 29 Aug 2017 09:00am EDT 

Aug 29 (Reuters) - Rockwell Medical Inc :Richmond Brothers Inc issues public letter to incumbent directors of Rockwell Medical Inc..Richmond Brothers Inc - calls for resignation or removal of Rob Chioini as Chairman and CEO of Rockwell.Richmond Brothers Inc says "believes Rockwell is actively obstructing mark H. Ravich's ability to exercise effective oversight as a board member".Richmond Brothers - call on Rockwell Medical board to pursue discussions with potential strategic partners in biopharmaceutical space, potential private equity partners.  Full Article

Rockwell Medical responds to Richmond Group
Tuesday, 29 Aug 2017 08:30am EDT 

Aug 29 (Reuters) - Rockwell Medical Inc :Issued statement concerning Richmond Group's filing of an amended schedule 13D with Securities and Exchange Commission.Rockwell Medical - Board does not believe it is in best interest of co for company to pay Richmond and Ravich the $875,000 they are demanding."Rockwell denies all of substantive allegations in Mr. Ravich's counterclaims".  Full Article

‍Richmond Brothers Inc​ seeks immediate replacement of Rockwell Medical CEO Robert Chioini
Monday, 28 Aug 2017 06:11pm EDT 

Aug 28 (Reuters) - ‍Richmond Brothers Inc​: ‍:Richmond Brothers Inc​ says it intends to nominate a competing slate of director candidates for Rockwell Medical Inc <<>>.Richmond Brothers Inc​ says it intends to nominate a competing slate of director candidates for Rockwell Medical Inc's board.‍richmond Brothers - while not advocating for sale of Rockwell Medical at this time, believes there are multiple paths to value creation and all paths should be evaluated.Richmond Brothers says intend to engage in discussions with private equity firms, among others, regarding a possible sale of Rockwell Medical.‍Richmond Brothers - to the extent there is strategic interest in Rockwell Medical, invites potential strategic acquirers to contact the Richmond Brothers.Richmond Brothers Inc and affiliates own 10.8 percent stake in Rockwell Medical Inc as of Aug 25, 2017 .  Full Article

Rockwell Medical Q2 loss per share $0.14
Wednesday, 9 Aug 2017 04:13pm EDT 

Aug 9 (Reuters) - Rockwell Medical Inc ::Rockwell medical reports second quarter results.Q2 loss per share $0.14.Q2 sales $13.2 million.  Full Article

BRIEF-Rockwell Medical Signs License Agreement With Quimica Europea To Commercialize Triferic In Peru

* ROCKWELL MEDICAL SIGNS EXCLUSIVE LICENSE AGREEMENT WITH QUIMICA EUROPEA TO COMMERCIALIZE TRIFERIC IN PERU